Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Agenus Inc (AGEN)

Agenus Inc (AGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 125,784
  • Shares Outstanding, K 20,999
  • Annual Sales, $ 156,310 K
  • Annual Income, $ -245,760 K
  • 60-Month Beta 1.32
  • Price/Sales 0.98
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AGEN with:

Options Overview Details

View History
  • Implied Volatility 132.01% ( -14.97%)
  • Historical Volatility 274.10%
  • IV Percentile 52%
  • IV Rank 16.04%
  • IV High 615.22% on 11/17/23
  • IV Low 39.67% on 08/14/23
  • Put/Call Vol Ratio 1.16
  • Today's Volume 1,941
  • Volume Avg (30-Day) 671
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 71,072
  • Open Int (30-Day) 67,103

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -2.04
  • Number of Estimates 4
  • High Estimate -0.02
  • Low Estimate -3.10
  • Prior Year -4.00
  • Growth Rate Est. (year over year) +49.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.73 +4.54%
on 07/19/24
18.74 -68.04%
on 07/16/24
-7.00 (-53.89%)
since 06/18/24
3-Month
4.91 +22.00%
on 04/22/24
19.69 -69.58%
on 06/04/24
+0.68 (+12.81%)
since 04/19/24
52-Week
4.78 +25.45%
on 04/18/24
34.20 -82.49%
on 07/20/23
-28.01 (-82.38%)
since 07/19/23

Most Recent Stories

More News
3 Magnificent Growth Stocks to Buy Hand Over Fist

Small-cap stocks could get a boost from the central bank's anticipated rate cuts in 2025. These three stocks may be a great way to get ahead of this catalyst.

LGND : 99.76 (+0.81%)
AGEN : 5.99 (-17.95%)
CGC : 7.13 (-1.25%)
CURLF : 4.1500 (-3.26%)
Agenus (AGEN) Q1 2024 Earnings Call Transcript

AGEN earnings call for the period ending March 31, 2024.

AGEN : 5.99 (-17.95%)
Agenus: Q1 Earnings Snapshot

Agenus: Q1 Earnings Snapshot

AGEN : 5.99 (-17.95%)
Up 40%: Is This Red-Hot Growth Stock Still a Buy?

This small-cap biotech stock is surging. Time to buy?

AGEN : 5.99 (-17.95%)
Down 75%. Is Agenus Stock a Buy on the Dip?

Wall Street analysts who watch the cancer drug developer closely think it could rocket higher.

RILY : 17.43 (-2.73%)
MRK : 125.77 (+1.22%)
BMY : 42.64 (+0.59%)
GSK : 39.35 (-0.03%)
AGEN : 5.99 (-17.95%)
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?

These stocks could rocket higher, but they also present significant risks.

BMY : 42.64 (+0.59%)
GSK : 39.35 (-0.03%)
RILY : 17.43 (-2.73%)
DNA : 0.2800 (-7.62%)
AGEN : 5.99 (-17.95%)
Agenus (AGEN) Q4 2023 Earnings Call Transcript

AGEN earnings call for the period ending December 31, 2023.

AGEN : 5.99 (-17.95%)
Agenus: Q4 Earnings Snapshot

Agenus: Q4 Earnings Snapshot

AGEN : 5.99 (-17.95%)
Why Agenus Stock Plummeted by Nearly 30% on Its Stock Split News Today

The company hopes to engineer a 1-for-20 reverse stock split.

NDAQ : 62.51 (+0.05%)
AGEN : 5.99 (-17.95%)
2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street

These two biotech stocks could be poised for a trend reversal.

BMY : 42.64 (+0.59%)
AGEN : 5.99 (-17.95%)
CHRS : 1.6400 (+4.46%)

Business Summary

Agenus Inc., formerly known as Antigenics Inc., is engaged in the discovery, development and commercialization of immunotherapeutics for the treatment of life threatening and chronic medical conditions. Immunotherapeutics are drugs that work by modulating the immune system to fight diseases. The Company's...

See More

Key Turning Points

3rd Resistance Point 8.50
2nd Resistance Point 7.90
1st Resistance Point 6.94
Last Price 5.99
1st Support Level 5.38
2nd Support Level 4.78
3rd Support Level 3.82

See More

52-Week High 34.20
Fibonacci 61.8% 22.96
Fibonacci 50% 19.49
Fibonacci 38.2% 16.02
Last Price 5.99
52-Week Low 4.78

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar